Anders Svensson joins OssDsign as Chief Financial Officer

Report this content

OssDsign AB (publ) (“OssDsign” or the “Company”) today announces that Anders Svensson, the Company’s current interim CFO, will take on the role permanently from April 1, 2021.

OssDsign has grown rapidly over the last several years and is now a global company with operations across three continents.  

Anders Svensson comes with a strong financial and strategic background and has senior management experience within a number of high growth companies. Prior to joining OssDsign, Anders was CFO for both Bluefish Pharmaceuticals and Aura Light, as well as being the CEO for Aura Light’s US business. Anders is Swedish native and holds a Master of Business Administration, Australian Graduate School of Management, University of New South Wales, Sydney, Australia.

“The fact that we have been able to attract Anders, who is an experienced executive with significant talent and competence, makes me excited and confident about OssDsign’s future. Anders comes with a wealth of CFO experience as well as a truly global understanding, not least from his years spent in the US and Australia. I am sure he will be able to add significant value to our value creation journey. As Anders has worked as our interim CFO since November 16 2020, he already knows the business and will therefore hit the ground running when he joins permanently on April 1”, says Morten Henneveld, CEO of OssDsign.

For further information, please contact:
Morten Henneveld, CEO, OssDsign AB
Tel: +46 73 382 43 90, email:

Certified Adviser:
Erik Penser Bank AB is the company’s Certified Adviser. Contact information: Erik Penser Bank AB, Box 7405, 103 91 Stockholm, Sweden, phone: +46 (0)8-463 80 00, email:

About OssDsign
OssDsign’s vision is to provide regenerative solutions to all patients with cranial or spinal bone defects, so they can be restored and healed as naturally as possible. Driven by a commitment to give patients back the lives they deserve, OssDsign collaborate with surgeons to engineer better healing by integrating biomaterials with clinical design. OssDsign is headquartered in Sweden but supplies hospitals globally with implants for use in cranial reconstructions and other orthopaedic surgery applications.